BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 18, 2022

View Archived Issues

Extracellular domains are not effective targets to disrupt intracellular HER2-HER3 tumor signaling

Read More

CECR2 promotes breast cancer metastasis through NF-kappaB signaling and immunosuppression

Read More

Neumora licenses rights to novel M4 receptor PAMs from Vanderbilt for schizophrenia

Read More

Monoclonal antibodies in AR-701 cocktail neutralize SARS-CoV-2 Omicron variant

Read More

New coagulation factor XIa inhibitors synthesized at Janssen Pharmaceutica

Read More

Merck & Co. presents new adenosine A2A and/or A2B receptor antagonists

Read More

New SREBP inhibitors identified at Capulus Therapeutics

Read More

Fog Pharmaceuticals describes stapled peptides targeting beta-catenin

Read More

New HSD17B13 inhibitors identified at Inipharm

Read More

Neurophilin-1 is an inhibitor of HIV-1 infectivity

Read More

Broadly neutralizing HCV antibodies isolated from high responders used to design new antibody

Read More

Using photoactivatable peptide toxins for modulation of voltage-gated ion channels

Read More

Nrf2 agonists ameliorate anemia of inflammation by disrupting the hepcidin-ferroportin axis

Read More

Targeting GDNF may have potential to treat IBD

Read More

New biomarkers identified to predict response to vedolizumab in patients with Crohn's disease

Read More

Targeting PFKFB3 reduces the severity of colitis in mouse models

Read More

EBV antibodies put to good use through retargeting

Read More

Mindset reports new benchmarking data on first-generation psychedelics

Read More

Repertoire Immune Medicines and UMass Chan collaborate to understand immune causes of vitiligo

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 11, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing